MarketCap
Facebook
X
TelegramAnnual report 2025
added 01-12-2026
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
32.5 K |
Market Cap[1] |
$ 92.5 K |
EBITDA (LTM) |
$ -19.2 M |
P/E (LTM) |
-8.28 |
P/S (LTM) |
0.06 |
EPS (LTM) |
-0.36 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 118.6 | 0.4 % | $ 36.1 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 107.62 | -0.63 % | $ 4.25 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Castle Biosciences
CSTL
|
$ 27.55 | -1.59 % | $ 765 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Charles River Laboratories International
CRL
|
$ 175.77 | -1.61 % | $ 8.71 B | NYSE,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 13.82 | -2.68 % | $ 418 M | Nasdaq Global Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 15.5 | -1.59 % | $ 2.01 B | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.12 | -1.78 % | $ 1.42 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 208.28 | -0.95 % | $ 23.1 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 204.04 | -0.9 % | $ 145 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.38 | 0.02 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.8 | 0.34 % | $ 551 M | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.3 | -4.19 % | $ 292 M | Nasdaq Capital Market |  Israel |
 |
DexCom
DXCM
|
$ 73.0 | -1.06 % | $ 28.5 B | Nasdaq Global Select Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 108.44 | 0.16 % | $ 8.94 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 635.29 | -0.22 % | $ 51.1 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
$ 24.01 | -4.59 % | $ 254 M | Nasdaq Global Market | China |
 |
Illumina
ILMN
|
$ 129.9 | -2.25 % | $ 20.7 B | Nasdaq Global Select Market,SPB | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | -0.74 % | $ 19.2 M | NYSE American |  Singapore |
 |
CareDx, Inc
CDNA
|
$ 18.74 | -0.03 % | $ 999 M | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Guardant Health
GH
|
$ 93.21 | 1.06 % | $ 11.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 283.19 | -1.07 % | $ 23.6 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 79.15 | 3.74 % | $ 5.34 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 174.33 | 0.03 % | $ 30 B | NYSE,SPB | USA |
 |
Brainsway Ltd.
BWAY
|
$ 23.2 | -2.09 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 315.61 | -0.56 % | $ 27.1 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 5.26 | 4.89 % | $ 487 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 9.53 | 0.26 % | $ 1.22 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Natera
NTRA
|
$ 206.39 | 3.11 % | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.51 | -7.1 % | $ 453 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 10.93 | -1.97 % | $ 2.37 B | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 24.78 | 0.38 % | $ 32.2 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.